Meetings Proceedings and Findings

Discover insights from AMCP's Partnership Forums and Advisory Groups, where key healthcare stakeholders collaborate to drive change. These events focus on enhancing efficiency, improving patient outcomes, and addressing industry issues. Access valuable perspectives and actionable recommendations to benefit your role and organization. Learn more about sponsorship benefits.

Meeting Proceedings & Findings

Role of Managed Care in Addressing Health Disparities Webinar Title Slide
Meeting Proceedings & Findings

AMCP Health Disparities Advisory Group

The Health Disparities Advisory Group is focused on developing resources related to data and formulary and utilization management solutions that can close the gap on disparities in medication use. This advisory group is active from March 2022-February 2023.
Health Disparities
Meeting Proceedings & Findings

High Investment Medications

Partnership Forum: The purpose of the forum was to identify concerns for high-investment medications related to predictability, affordability, and accessibility. Participants also explored alternative payments, financial tools, and policy initiatives related to these medications.
Value-Based Care
AMCP Health Technology Assessment Partnership Forum
Meeting Proceedings & Findings

Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement

Partnership Forum: This Partnership Forum identified opportunities to improve how value assessments are developed and applied to formulary decision-making and provide strategies and guidance on best practices to equip managed care pharmacists and other professionals when applying these tools to assess value and optimize patient care.
Health Technology, Value-Based Care
Digital Therapeutics Partnership Forum
Meeting Proceedings & Findings

Digital Therapeutics 2.0

Partnership Forum: This forum identified challenges and payer needs related to the evidence for digital therapeutics. The forum explored the current market space for digital therapeutics including the evidence for the products, place in therapy, monitoring or utilization metrics and barriers that patients face in obtaining therapies. Proceedings are now available.
Digital Therapeutics
Meeting Proceedings & Findings

Summit on Immunoglobulin

Immunoglobulin (IG) derived from the plasma of donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders. To understand the appropriate and cost effective use of immunoglobulin, AMCP convened an expert panel of managed care stakeholders.